Business Services Industry
Horizon Health Announces First Quarter Results
Business Wire, Jan 10, 2005
LEWISVILLE, Texas -- Horizon Health Corporation (NASDAQ/NM:HORC) today announced earnings of $0.52 per diluted share for the first fiscal quarter ended November 30, 2004, an increase of 13.0%, as compared with earnings of $0.46 per diluted share for the prior year quarter. Revenues increased 23.9% to $52.1 million compared with revenues of $42.0 million for the same quarter in the previous year, and net income increased 15.5% to $3.0 million compared with net income of $2.6 million for the prior year period.
Mr. Ken Newman, president and chief executive officer of Horizon Health, said, "We are pleased with the double-digit year-over-year increases in revenue, net income, and earnings per share resulting from increases in same store sales and accretive acquisitions made in furtherance of our focused growth strategy."
The Company also stated that it currently believes the new PPS rules for psychiatric services will not have a material adverse effect on its contract management business or on its owned freestanding behavioral health hospitals in fiscal 2005. The Company is not revising its previously announced guidance of estimated earnings per share of $2.16 for fiscal 2005.
A listen-only simulcast and a 30-day replay of Horizon's first quarter results call will be available online on January 11, 2005, beginning at 10:00 a.m. Central Time through the Company's website at www.horizonhealth.com or at www.fulldisclosure.com.
Horizon Health is a leading manager and a provider of behavioral health and physical rehabilitation clinical services and a provider of employee assistance plans and behavioral services to businesses and managed care organizations.
The statements contained herein based on future expectations rather than on historical facts are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Numerous factors as outlined in the SEC Report filed by the Company could cause actual results to differ materially from those in any such forward-looking statements. There can be no assurance that statements made in this press release relating to future events will be achieved. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.
HORIZON HEALTH
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share and statistical data)
For the Three Months
Ended November 30,
---------------------
2004 2003
--------- ---------
Revenue $52,078 $42,047
Cost of Services 39,297 32,484
--------- ---------
Gross Profit 12,781 9,563
Selling, general and administrative 5,758 4,905
Provision for (recovery of)
doubtful accounts 864 (266)
Depreciation and amortization 888 662
--------- ---------
Income from operations 5,271 4,262
Interest expense (net of
interest and other income) 382 79
--------- ---------
Income before income taxes 4,889 4,183
Income tax provision 1,907 1,602
--------- ---------
Net income $2,982 $2,581
========= =========
Net income per common and
common equivalent share
Basic $0.54 $0.48
========= =========
Diluted $0.52 $0.46
========= =========
Weighted average shares outstanding
Basic 5,533 5,366
Diluted 5,703 5,650
CONSOLIDATED BALANCE SHEETS
Nov. 30, August 31,
2004 2004
--------- ---------
Cash $1,925 $1,908
Accounts receivable (net) 24,453 22,059
Other current assets 5,611 4,823
--------- ---------
Total current assets 31,989 28,790
Property and equipment (net) 28,636 28,801
Goodwill and other intangible assets (net) 86,929 87,244
Other long-term assets 324 430
--------- ---------
Total assets $147,878 $145,265
========= =========
Current liabilities $22,504 $23,230
Other liabilities 2,276 1,570
Long-term debt 38,000 40,000
Deferred taxes 5,008 4,641
--------- ---------
Total liabilities 67,788 69,441
Stockholders' equity 80,090 75,824
--------- ---------
Total liabilities and
stockholders' equity $147,878 $145,265
========= =========
SUMMARY STATISTICAL DATA
Quarter
Ended As of August 31,
Nov. 30, -------------------------------------------------
2004 2004 2003 2002 2001 2000
--------- --------- --------- --------- --------- ---------
Number of
contract
locations:
Contract
locations in
operation 128 132 127 131 124 128
Contract
locations
signed &
unopened 11 8 15 11 14 10
--------- --------- --------- --------- --------- ---------
Total
contract
locations 139 140 142 142 138 138
========= ========= ========= ========= ========= =========
Licensed
Beds 269 269 -- -- -- --
Managed
Care
and EAP
Lives 3,645,312 3,543,960 3,217,406 2,349,197 2,208,938 1,736,078
Managed
Care
and EAP
Contracts 1,164 1,175 1,175 687 641 258
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


